BHAV Acquisition Corp — Q3 2026 Form 10-Q
Reporting period: Quarter ended September 30, 2026; financial statements are unaudited. BHAV is a blank-check company and had not commenced operating activities by quarter-end. It seeks a business combination, with stated focus areas including robotics, EVs, drones/UAS and fintech. The filing was signed November 17, 2026.
Financial position and results
| Metric | Q3 / September 30, 2026 | Nine months ended September 30, 2026 |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expenses | $319,254 | $677,322 |
| Interest income from Trust Account investments | $932,527 | $1,911,970 |
| Net income | $612,178 | $1,325,352 |
| Net income per share, Class A and Class B | $0.04 each | $0.12 each |
| Cash used in operating activities | Not separately stated | $514,188 |
| Cash and working capital | $496,813 and $342,140 | — |
| Trust Account investments | $101,911,970 | — |
Net income reflects Trust Account interest rather than operating earnings. Nine-month income also included a $93,900 gain from expiration of the underwriters’ over-allotment option, partly offset by $3,196 of financed-loan interest expense. No operating margin is meaningful because the company had no operating revenue.
At September 30, current liabilities were $297,091, including a $31,439 financed insurance-premium loan; the company reported no long-term debt. Redeemable Class A shares were presented as $101,911,970 of temporary equity. Total shareholders’ equity was $342,140. The Trust Account held money-market funds invested primarily in U.S. Treasuries.
Changes versus prior period
The company completed its IPO on March 20, 2026, raising $100 million from 10 million units, and sold $2 million of private-placement units. It deposited $100 million in the Trust Account. Compared with December 31, 2025, cash increased from $25,000 to $496,813, while Trust Account investments increased from zero to $101,911,970. The prior-year statement covers only the period from inception on September 29 through September 30, 2025, when the company recorded an $18,021 loss; it is not a comparable full-quarter operating period.
On May 3, 2026, the over-allotment option expired unexercised and 500,000 Founder Shares were forfeited. As of September 30, 700,000 nonredeemable Class A shares and 3,333,333 Class B shares were outstanding, in addition to 10 million redeemable public shares. The cover reports 10.7 million Class A and 3,333,333 Class B shares outstanding as of November 13, 2026.
Business combination, outlook and risks
On November 3, 2026, after quarter-end, BHAV entered into a business combination agreement with Nemi Corp. and related parties. Nemi is described as a physical-AI and manufacturing-as-a-service company, with Indian subsidiaries operating manufacturing facilities. The proposed transaction would provide Nemi equity holders an aggregate 40 million newly issued Pubco shares at a deemed $10 per share, or $400 million; that total includes shares for equity awards and permitted financing securities, reducing shares allocated to existing Nemi holders accordingly. The transaction remains conditional and is not assured to close.
Closing conditions include BHAV shareholder approval, an effective Form S-4, Nasdaq listing approval, material regulatory approvals, specified BNC restructuring steps and at least $30 million of available closing cash. Nemi may raise additional capital before closing. Public-share redemptions could reduce cash available. The agreement may be terminated if closing has not occurred by June 20, 2027, or an approved extended deadline. BHAV’s 15-month combination period ends June 20, 2027 unless extended.
Management disclosed substantial doubt about the company’s ability to continue as a going concern, citing its liquidity position and mandatory liquidation within 12 months of the financial-statement date. The company says sponsor or affiliate loans may be available for transaction costs, but those parties are not obligated to lend. If BHAV fails to complete a business combination within the combination period, it must cease operations, redeem public shares and liquidate; rights would expire worthless.
The filing highlights potential substantial dilution from Nemi’s 40 million-share consideration, Founder Shares, Representative Shares, private-placement securities, rights conversion, possible financings and an equity incentive plan initially covering 15% of Pubco’s fully diluted shares, with an annual evergreen increase. The proposed dual-class structure gives specified holders 10 votes per Class B share, potentially concentrating voting control. Sponsor and management interests may differ from public shareholders’ interests. Other disclosed risks include geopolitical and market disruption, transaction execution, redemption levels, access to financing and the Sponsor’s uncertain ability to satisfy its Trust Account indemnity.
No operating-revenue guidance or earnings forecast is provided. Management expects continuing reporting, transaction, due-diligence and working-capital costs. Disclosure controls were assessed as effective at a reasonable-assurance level; no material quarterly change in internal control over financial reporting was reported. No legal proceedings were reported.
Important facts for investors to verify
- Review the definitive transaction documents and future Form S-4 for closing conditions, financing terms, redemptions, final ownership and fully diluted share counts.
- Track the $30 million minimum available closing cash condition against Trust Account funds, redemptions, transaction costs and any financing.
- Confirm the June 20, 2027 deadline and whether shareholders approve any extension, including its redemption consequences.
- Assess dilution, the 15% initial equity-plan pool and evergreen provision, dual-class voting control, lock-ups and related-party interests.
- Monitor cash outside the Trust Account, transaction spending, potential sponsor loans and the going-concern warning.